FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3012611938> ?p ?o ?g. }

• W3012611938 endingPage "100107" @default.
• W3012611938 startingPage "100107" @default.
• W3012611938 abstract "ObjectiveThe aim of this systematic review was to report pregnancy and perinatal outcomes of coronavirus spectrum infections, and particularly coronavirus 2019 (COVID-19) disease because of severe acute respiratory syndrome–coronavirus-2 infection during pregnancy.Data SourcesMedline, Embase, Cinahl, and Clinicaltrials.gov databases were searched electronically utilizing combinations of word variants for coronavirus or severe acute respiratory syndrome or SARS or Middle East respiratory syndrome or MERS or COVID-19 and pregnancy. The search and selection criteria were restricted to English language.Study Eligibility CriteriaInclusion criteria were hospitalized pregnant women with a confirmed coronavirus related–illness, defined as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), or COVID-19.Study Appraisal and Synthesis MethodsWe used meta-analyses of proportions to combine data and reported pooled proportions, so that a pooled proportion may not coincide with the actual raw proportion in the results. The pregnancy outcomes observed included miscarriage, preterm birth, preeclampsia, preterm prelabor rupture of membranes, fetal growth restriction, and mode of delivery. The perinatal outcomes observed were fetal distress, Apgar score <7 at 5 minutes, neonatal asphyxia, admission to a neonatal intensive care unit, perinatal death, and evidence of vertical transmission.ResultsNineteen studies including 79 hospitalized women were eligible for this systematic review: 41 pregnancies (51.9%) affected by COVID-19, 12 (15.2%) by MERS, and 26 (32.9%) by SARS. An overt diagnosis of pneumonia was made in 91.8%, and the most common symptoms were fever (82.6%), cough (57.1%), and dyspnea (27.0%). For all coronavirus infections, the pooled proportion of miscarriage was 64.7% (8/12; 95% confidence interval, 37.9-87.3), although reported only for women affected by SARS in two studies with no control group; the pooled proportion of preterm birth <37 weeks was 24.3% (14/56; 95% confidence interval, 12.5–38.6); premature prelabor rupture of membranes occurred in 20.7% (6/34; 95% confidence interval, 9.5–34.9), preeclampsia in 16.2% (2/19; 95% confidence interval, 4.2–34.1), and fetal growth restriction in 11.7% (2/29; 95% confidence interval, 3.2–24.4), although reported only for women affected by SARS; 84% (50/58) were delivered by cesarean; the pooled proportion of perinatal death was 11.1% (5/60; 95% confidence interval, 84.8–19.6), and 57.2% of newborns (3/12; 95% confidence interval, 3.6–99.8) were admitted to the neonatal intensive care unit. When focusing on COVID-19, the most common adverse pregnancy outcome was preterm birth <37 weeks, occurring in 41.1% of cases (14/32; 95% confidence interval, 25.6–57.6), while the pooled proportion of perinatal death was 7.0% (2/41; 95% confidence interval, 1.4–16.3). None of the 41 newborns assessed showed clinical signs of vertical transmission.ConclusionIn hospitalized mothers infected with coronavirus infections, including COVID-19, >90% of whom also had pneumonia, preterm birth is the most common adverse pregnancy outcome. COVID-19 infection was associated with higher rate (and pooled proportions) of preterm birth, preeclampsia, cesarean, and perinatal death. There have been no published cases of clinical evidence of vertical transmission. Evidence is accumulating rapidly, so these data may need to be updated soon. The findings from this study can guide and enhance prenatal counseling of women with COVID-19 infection occurring during pregnancy, although they should be interpreted with caution in view of the very small number of included cases. The aim of this systematic review was to report pregnancy and perinatal outcomes of coronavirus spectrum infections, and particularly coronavirus 2019 (COVID-19) disease because of severe acute respiratory syndrome–coronavirus-2 infection during pregnancy. Medline, Embase, Cinahl, and Clinicaltrials.gov databases were searched electronically utilizing combinations of word variants for coronavirus or severe acute respiratory syndrome or SARS or Middle East respiratory syndrome or MERS or COVID-19 and pregnancy. The search and selection criteria were restricted to English language. Inclusion criteria were hospitalized pregnant women with a confirmed coronavirus related–illness, defined as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), or COVID-19. We used meta-analyses of proportions to combine data and reported pooled proportions, so that a pooled proportion may not coincide with the actual raw proportion in the results. The pregnancy outcomes observed included miscarriage, preterm birth, preeclampsia, preterm prelabor rupture of membranes, fetal growth restriction, and mode of delivery. The perinatal outcomes observed were fetal distress, Apgar score <7 at 5 minutes, neonatal asphyxia, admission to a neonatal intensive care unit, perinatal death, and evidence of vertical transmission. Nineteen studies including 79 hospitalized women were eligible for this systematic review: 41 pregnancies (51.9%) affected by COVID-19, 12 (15.2%) by MERS, and 26 (32.9%) by SARS. An overt diagnosis of pneumonia was made in 91.8%, and the most common symptoms were fever (82.6%), cough (57.1%), and dyspnea (27.0%). For all coronavirus infections, the pooled proportion of miscarriage was 64.7% (8/12; 95% confidence interval, 37.9-87.3), although reported only for women affected by SARS in two studies with no control group; the pooled proportion of preterm birth <37 weeks was 24.3% (14/56; 95% confidence interval, 12.5–38.6); premature prelabor rupture of membranes occurred in 20.7% (6/34; 95% confidence interval, 9.5–34.9), preeclampsia in 16.2% (2/19; 95% confidence interval, 4.2–34.1), and fetal growth restriction in 11.7% (2/29; 95% confidence interval, 3.2–24.4), although reported only for women affected by SARS; 84% (50/58) were delivered by cesarean; the pooled proportion of perinatal death was 11.1% (5/60; 95% confidence interval, 84.8–19.6), and 57.2% of newborns (3/12; 95% confidence interval, 3.6–99.8) were admitted to the neonatal intensive care unit. When focusing on COVID-19, the most common adverse pregnancy outcome was preterm birth <37 weeks, occurring in 41.1% of cases (14/32; 95% confidence interval, 25.6–57.6), while the pooled proportion of perinatal death was 7.0% (2/41; 95% confidence interval, 1.4–16.3). None of the 41 newborns assessed showed clinical signs of vertical transmission. In hospitalized mothers infected with coronavirus infections, including COVID-19, >90% of whom also had pneumonia, preterm birth is the most common adverse pregnancy outcome. COVID-19 infection was associated with higher rate (and pooled proportions) of preterm birth, preeclampsia, cesarean, and perinatal death. There have been no published cases of clinical evidence of vertical transmission. Evidence is accumulating rapidly, so these data may need to be updated soon. The findings from this study can guide and enhance prenatal counseling of women with COVID-19 infection occurring during pregnancy, although they should be interpreted with caution in view of the very small number of included cases." @default.
• W3012611938 created "2020-03-27" @default.
• W3012611938 creator A5010862015 @default.
• W3012611938 creator A5026048739 @default.
• W3012611938 creator A5028099145 @default.
• W3012611938 creator A5050782244 @default.
• W3012611938 creator A5065033288 @default.
• W3012611938 creator A5074270038 @default.
• W3012611938 creator A5076938107 @default.
• W3012611938 creator A5078658418 @default.
• W3012611938 creator A5080869614 @default.
• W3012611938 creator A5090207334 @default.
• W3012611938 creator A5091604332 @default.
• W3012611938 date "2020-05-01" @default.
• W3012611938 modified "2023-10-16" @default.
• W3012611938 title "Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis" @default.
• W3012611938 cites W1551228934 @default.
• W3012611938 cites W1603742549 @default.
• W3012611938 cites W1979423827 @default.
• W3012611938 cites W2005501262 @default.
• W3012611938 cites W2028042221 @default.
• W3012611938 cites W2041013541 @default.
• W3012611938 cites W2058694455 @default.
• W3012611938 cites W2068176671 @default.
• W3012611938 cites W2112410788 @default.
• W3012611938 cites W2122200789 @default.
• W3012611938 cites W2130515362 @default.
• W3012611938 cites W2263572070 @default.
• W3012611938 cites W2280966491 @default.
• W3012611938 cites W2290018439 @default.
• W3012611938 cites W2306794997 @default.
• W3012611938 cites W2331925823 @default.
• W3012611938 cites W2411422947 @default.
• W3012611938 cites W2474234222 @default.
• W3012611938 cites W2753677525 @default.
• W3012611938 cites W2785755264 @default.
• W3012611938 cites W2806669511 @default.
• W3012611938 cites W3001118548 @default.
• W3012611938 cites W3005679569 @default.
• W3012611938 cites W3008223050 @default.
• W3012611938 cites W3009155494 @default.
• W3012611938 cites W3009589824 @default.
• W3012611938 cites W3009839849 @default.
• W3012611938 cites W3010447819 @default.
• W3012611938 cites W3165656738 @default.
• W3012611938 doi "https://doi.org/10.1016/j.ajogmf.2020.100107" @default.
• W3012611938 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7104131" @default.
• W3012611938 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32292902" @default.
• W3012611938 hasPublicationYear "2020" @default.
• W3012611938 type Work @default.
• W3012611938 sameAs 3012611938 @default.
• W3012611938 citedByCount "759" @default.
• W3012611938 countsByYear W30126119382020 @default.
• W3012611938 countsByYear W30126119382021 @default.
• W3012611938 countsByYear W30126119382022 @default.
• W3012611938 countsByYear W30126119382023 @default.
• W3012611938 crossrefType "journal-article" @default.
• W3012611938 hasAuthorship W3012611938A5010862015 @default.
• W3012611938 hasAuthorship W3012611938A5026048739 @default.
• W3012611938 hasAuthorship W3012611938A5028099145 @default.
• W3012611938 hasAuthorship W3012611938A5050782244 @default.
• W3012611938 hasAuthorship W3012611938A5065033288 @default.
• W3012611938 hasAuthorship W3012611938A5074270038 @default.
• W3012611938 hasAuthorship W3012611938A5076938107 @default.
• W3012611938 hasAuthorship W3012611938A5078658418 @default.
• W3012611938 hasAuthorship W3012611938A5080869614 @default.
• W3012611938 hasAuthorship W3012611938A5090207334 @default.
• W3012611938 hasAuthorship W3012611938A5091604332 @default.
• W3012611938 hasBestOaLocation W30126119381 @default.
• W3012611938 hasConcept C116675565 @default.
• W3012611938 hasConcept C126322002 @default.
• W3012611938 hasConcept C144237770 @default.
• W3012611938 hasConcept C148220186 @default.
• W3012611938 hasConcept C159047783 @default.
• W3012611938 hasConcept C2777648638 @default.
• W3012611938 hasConcept C2778137277 @default.
• W3012611938 hasConcept C2779134260 @default.
• W3012611938 hasConcept C2779234561 @default.
• W3012611938 hasConcept C2909376813 @default.
• W3012611938 hasConcept C3006700255 @default.
• W3012611938 hasConcept C3007834351 @default.
• W3012611938 hasConcept C3008058167 @default.
• W3012611938 hasConcept C33923547 @default.
• W3012611938 hasConcept C524204448 @default.
• W3012611938 hasConcept C54355233 @default.
• W3012611938 hasConcept C71924100 @default.
• W3012611938 hasConcept C86803240 @default.
• W3012611938 hasConcept C89623803 @default.
• W3012611938 hasConcept C95190672 @default.
• W3012611938 hasConceptScore W3012611938C116675565 @default.
• W3012611938 hasConceptScore W3012611938C126322002 @default.
• W3012611938 hasConceptScore W3012611938C144237770 @default.
• W3012611938 hasConceptScore W3012611938C148220186 @default.
• W3012611938 hasConceptScore W3012611938C159047783 @default.
• W3012611938 hasConceptScore W3012611938C2777648638 @default.
• W3012611938 hasConceptScore W3012611938C2778137277 @default.
• W3012611938 hasConceptScore W3012611938C2779134260 @default.
• W3012611938 hasConceptScore W3012611938C2779234561 @default.

• next